Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2026 highlights: Astra, CSPC sign up to US$ 18.5 bn obesity deal; Wegovy’s pill version debuts in US

    Stock Recap
    #PipelineProspector

    Menu

    Urinastatin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/01/2026 BSV Bioscience GmbH
    Germany
    		 Sampoong Finechem Co., Ltd. 20210630-210-J-1047 Urinastatin 2021-06-30 BSV BioScience GmbH Germany Max-Planck-Strasse 12, 52499 Baesweiler, Germany
    02/02/2026 Jiangxi Haoran Biopharma Co Ltd
    China
    		 Hiple Co., Ltd. 20251204-210-J-2061 Urinastatin 2025-12-04 Jiangxi Haoran Bio-pharma Co., Ltd. China No. 369 Youkou Road, High-Tech Industry Development Zone, Nanchang, Jiangxi, China
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.